Evidence map›Paper›PMID 22859970›Full record

ArticlePloS one2012

Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clones.

Umaer Naseer, Barbro E Olsson-Liljequist, Neil Woodford, Hiran Dhanji, Rafael Cantón, Arnfinn Sundsfjord, Bjørn-Arne Lindstedt

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Subtyping β-lactamase-producingIranian journal of basic medical sciences · 2021
    Article
  6. High Prevalence of ST131 Subclades C2-Frontiers in cellular and infection microbiology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genotypic characterization of gentamicin and cephalosporin resistantAntimicrobial resistance and infection control · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Escherichia coli ST131, an intriguing clonal group.Clinical microbiology reviews · 2014
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Umaer NaseerResearch Group for Host-Microbe Interactions, Department of Medical Biology, University of Tromsø, Tromsø, Norway. umaer.naseer@uit.no
Barbro E Olsson-Liljequist
Neil Woodford
Hiran Dhanji
Rafael Cantón
Arnfinn Sundsfjord
Bjørn-Arne Lindstedt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One hundred E. coli isolates from Norway (n = 37), Sweden (n = 24), UK (n = 20) and Spain (n = 19), producing CTX-M-type - (n = 84), or SHV-12 (n = 4) extended spectrum β-lactamases, or the plasmid mediated AmpC, CMY-2 (n = 12), were typed using multi-locus sequence typing (MLST) and multi-locus variable number of tandem repeat analysis (MLVA). Isolates clustered into 33 Sequence Types (STs) and 14 Sequence Type Complexes (STCs), and 58 MLVA-Types (MTs) and 25 different MLVA-Type Complexes (MTCs). A strong agreement between the MLST profile and MLVA typing results was observed, in which all ST131-isolates (n = 39) and most of the STC-648 (n = 10), STC-38 (n = 9), STC-10 (n = 9), STC-405 (n = 8) and STC-23 (n = 6) isolates were clustered distinctly into MTC-29, -36, -20, -14, -10 and -39, respectively. MLVA is a rapid and accurate tool for genotyping isolates of globally disseminated virulent multidrug resistant E. coli lineages, including ST131.

Indexed as

Minisatellite RepeatsMultilocus Sequence TypingBacterial Typing Techniquesbeta-LactamasesDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsNorwaySpainSwedenUnited Kingdombeta-lactamase CMY-2beta-Lactamasesbeta-lactamase SHV-12CTX-M-27, E coliEscherichia coli Proteins

Identifiers

PMID22859970
PMCPMC3407997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.